Uncover key drivers, emerging technologies, and competitive movements shaping the advanced therapeutics pharmaceutical outsourcing market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Advanced Therapeutics Pharmaceutical Outsourcing Market show for the 2026–2030 period?
The advanced therapeutics pharmaceutical outsourcing market has experienced consistent expansion in recent years. This market is set to increase from $8.41 billion in 2025 to $8.82 billion in 2026, registering a compound annual growth rate (CAGR) of 5.0%. The historical growth of this market is primarily due to an expanding biologics pipeline, the significant cost of in-house manufacturing, the rising occurrence of oncology and rare diseases, a lack of internal expertise in advanced therapies, and the global spread of clinical trials.
The advanced therapeutics pharmaceutical outsourcing market size is anticipated to experience robust expansion over the next few years. It is projected to achieve $10.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.0%. The projected growth during this period stems from factors such as increasing adoption of personalized medicine, the broadening of commercial-scale cell and gene therapies, escalating regulatory complexity, a significant rise in biotech start-up funding, and the requirement for a faster time-to-market. Prominent trends for the forecast period encompass an increasing reliance on outsourcing for cell and gene therapy manufacturing, an escalating need for comprehensive CDMO services, the development of specialized viral vector production capabilities, a greater emphasis on support for regulatory and quality compliance, and expedited clinical trial outsourcing for rare and complex indications.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
What Drivers Are Shaping The Development Of The Advanced Therapeutics Pharmaceutical Outsourcing Market?
The future expansion of the advanced therapeutics pharmaceutical outsourcing market is anticipated to be driven by the growing embrace of cell and gene therapies. These therapies represent cutting-edge medical approaches, leveraging living cells or genetic material to address or resolve illnesses. Within the realm of cell and gene therapies, advanced therapeutics pharmaceutical outsourcing provides companies with access to established providers and skilled staff, thereby conserving time and resources that would otherwise be spent on internal team development. As an illustration, IQVIA Holdings Inc., a US-based firm specializing in advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare sectors, reported in March 2024 that worldwide expenditure on cell and gene therapies climbed significantly to $5.9 billion in 2023, marking a 38% increase compared to 2022. Consequently, the rising acceptance of cell and gene therapies is a primary factor fueling the expansion of the advanced therapeutics pharmaceutical outsourcing market.
What Segment Types Are Examined In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
What Upcoming Trends Are Likely To Define The Future Path Of The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Prominent companies active in the advanced therapeutics pharmaceutical outsourcing market are emphasizing strategic partnerships to deliver trustworthy services to clients. A strategic partnership involves a cooperative agreement between two or more organizations, typically businesses, established to accomplish mutually advantageous objectives that each participant could not achieve independently. For example, in January 2023, Lonza, a Switzerland-based manufacturing firm for the pharmaceutical, biotechnology, and nutrition industries, collaborated with Context Therapeutics Inc., a US-based biopharmaceutical company focused on developing medicines for solid tumors. This collaboration includes Lonza offering manufacturability assessment, gene and cell line construction, and process development for the drug substance and drug product.
Who Are The Major Companies Operating In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, AGC Biologics, Evotec SE, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cytovance Biologics
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2025. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Advanced Therapeutics Pharmaceutical Outsourcing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13768&type=smp
Browse Through More Reports Similar to the Global Advanced Therapeutics Pharmaceutical Outsourcing Market 2026, By The Business Research Company
Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026
Pharmaceutical Fill And Finish Outsourcing Market Report 2026
Biologics Outsourcing Market Report 2026
https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model